Why Add  Tyvaso?

Why settle for doing okay on a single oral therapy, when adding Tyvaso could help you improve your exercise ability?

Adding Tyvaso has been shown to help patients already taking oral therapy (bosentan, an endothelin receptor antagonist [ERA], or sildenafil, a phosphodiesterase-5 [PDE-5] inhibitor) to improve their 6-minute walk distance (6MWD) (exercise ability) by an average of 20 meters. This could mean improvement in your ability to walk to the mailbox, take a short stroll in the neighborhood, or walk your kids to the bus stop.

Make improvement the goal

Physical symptoms may not always reflect whether PAH is progressing or how it is affecting the heart. Making sure you are meeting your treatment goals is one way to assess your progress. The 6MWD is one of several measures doctors use to determine how well you’re doing and the effects of your PAH treatment. Do you know what your 6MWD is? Download the Doctor Discussion Guide, and talk to your doctor about your 6MWD and if Tyvaso could help you go farther.

Tyvaso Patient Brochure

Learn more about adding Tyvaso to your oral therapy.

Selected Important Safety Information

Next: See How Tyvaso Works


Before you take Tyvaso, tell your healthcare provider about all of your medical conditions, including if you:

It is important to tell your healthcare provider about all the medicines you may be taking, including prescription and non-prescription medicines, vitamins, and herbal supplements, as they may affect your use of Tyvaso by increasing the risk of side effects or decreasing effectiveness. Especially tell your healthcare provider if you take any of these medicines:

The most common side effects of Tyvaso are coughing, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), and fainting or loss of consciousness. These are not all the possible side effects of Tyvaso. Tell your healthcare provider about any side effects that bother you or do not go away. Your healthcare provider may be able to help you manage the side effects.


Tyvaso is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH) (WHO Group 1), which is high blood pressure in the arteries of your lungs. Tyvaso can improve exercise ability in people who also take bosentan (an endothelin receptor antagonist, (ERA)) or sildenafil (a phosphodiesterase-5 (PDE-5) inhibitor). Your ability to do exercise decreases 4 hours after taking Tyvaso.

The effects of Tyvaso are unknown in patients under 18 years of age.


Please see the Full Prescribing Information, Patient Package Insert, and the Tyvaso Inhalation System Instructions for Use manual.

For additional information about Tyvaso, visit www.tyvaso.com or call 1-877-UNITHER (1-877-864- 8437).

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.